Bourdeau, Isabelle

ARMC5 Mutations Are a Frequent Cause of Primary Macronodular Adrenal Hyperplasia

Alencar, G. A., Lerario, A. M., Nishi, M. Y., Mariani, B. M. D. P., Almeida, M. Q., Tremblay, J., Hamet, P., Bourdeau, I., Zerbini, M. C. N., Pereira, M. A. A., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 162

Frequent mutations of β‐catenin gene in sporadic secreting adrenocortical adenomas*

Tadjine, M., Lampron, A., Ouadi, L., & Bourdeau, I. (2008) · Clinical Endocrinology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 153

CT characteristics of pheochromocytoma: relevance for the evaluation of adrenal incidentaloma

Canu, L., Van Hemert, J. A. W., Kerstens, M. N., Hartman, R. P., Khanna, A., Kraljevic, I., Kastelan, D., Badiu, C., Ambroziak, U., Tabarin, A., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsNeuroendocrine Tumor Research Advances

Cited by 131

Detection of somatic β-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD)

Tadjine, M., Lampron, A., Ouadi, L., Horvath, A., Stratakis, C. A., & Bourdeau, I. (2008) · Clinical Endocrinology

Adrenal and Paraganglionic TumorsPituitary Gland Disorders and Treatments

Cited by 108

Management of endocrine disease: differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas

Bourdeau, I., El Ghorayeb, N., Gagnon, N., & Lacroix, A. (2018) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 98

Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients

Fragoso, M. C. B. V., Almeida, M. Q., Mazzuco, T. L., Mariani, B. M. P., Brito, L. P., Gonçalves, T. C., Alencar, G. A., Lima, L. D. O., Faria, A. M., Bourdeau, I., et al. (2012) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsSarcoma Diagnosis and Treatment

Cited by 93

Multiple aberrant hormone receptors in Cushing’s syndrome

Ghorayeb, N. E., Bourdeau, I., & Lacroix, A. (2015) · European Journal of Endocrinology

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 90

Primary bilateral macronodular adrenal hyperplasia

De Venanzi, A., Alencar, G. A., Bourdeau, I., Fragoso, M. C. B. V., & Lacroix, A. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 73

Impact of Intravenous Insulin on 18F-FDG PET in Diabetic Cancer Patients

Roy, F.-N., Beaulieu, S., Boucher, L., Bourdeau, I., & Cohade, C. (2009) · Journal of Nuclear Medicine

Medical Imaging Techniques and ApplicationsHyperglycemia and glycemic control in critically ill and hospitalized patients

Cited by 63

Adrenocortical hyperplasia: A multifaceted disease

Bourdeau, I., Parisien-La Salle, S., & Lacroix, A. (2020) · Best Practice & Research Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsAdrenal Hormones and Disorders

Cited by 48

Adrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment.

Mazzuco, T. L., Bourdeau, I., & Lacroix, A. (2009) · Current Opinion in Endocrinology, Diabetes & Obesity

Adrenal and Paraganglionic TumorsPituitary Gland Disorders and Treatments

Cited by 48

Pasireotide monotherapy in Cushing’s disease: a single-centre experience with 5-year extension of phase III Trial

MacKenzie Feder, J., Bourdeau, I., Vallette, S., Beauregard, H., Ste-Marie, L.-G., & Lacroix, A. (2014) · Pituitary

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic Tumors

Cited by 38

Identification of Genetic Alterations of AXIN2 Gene in Adrenocortical Tumors

Chapman, A., Durand, J., Ouadi, L., & Bourdeau, I. (2011) · The Journal of Clinical Endocrinology & Metabolism

Adrenal and Paraganglionic TumorsWnt/β-catenin signaling in development and cancer

Cited by 28